ATRO ASTRONICS CORP Insider Trading

Director Robert S. Keane sells 237.7K shares at $26.93 avg for $6.4M; post-transaction holdings zero from derivatives conversion.

Director Robert S. Keane executed 2 separate sales totaling 237.7K shares for $6,401,050.00 on May 8–9, 2025, at a blended average price of $26.93. The current stock price is $29.19, representing a +8.4% premium to the sales. Notably, this filing involves a derivative-conversion transaction, meaning the insider's real economic position resides in Table II derivative securities not yet populated in the database; the zero Table I holdings post-transaction does not necessarily indicate a complete exit from economic exposure. His prior sales at ATRO show a -9.1% 30-day return, though longer-term outcomes remain unmeasurable. His cross-ticker track record shows 9 prior sells with a 100.00% well-timed rate at the 90-day mark (avg 90d return -19.4%), suggesting historical skill in sell timing, but timing evaluation for this transaction is premature pending derivative position disclosure.

Director Keane sells entire 77,099-share position at $24.55 for $1.9M; stock up 50.8% in 90 days from unprofitable base.

Director Robert S Keane liquidated his entire holding of 77,099 shares through 2 separate sales totaling $1,892,780.45 at $24.55 per share on 2025-03-07, reducing his position from 77,099 shares to 0 shares post-transaction. The complete exit occurs against a backdrop of significant recent price appreciation: the stock has risen 50.8% over the past 90 days and 28.6% over the past 30 days, now trading at $24.59—only 1.3% below its 52-week high of $24.91. This timing is notable given Astronics' fundamental challenges: the company reported negative net income of $-11.7M in the latest quarter and was unprofitable over its most recent full fiscal year, despite posting 15.4% annual revenue growth to $203.7M and a strained valuation (P/E of 204.92 driven by the loss). Keane's cross-ticker track record shows 7 prior open-market sells with a 100.00% well-timed rate over 90 days, meaning the stock fell after those sales—a pattern that historically has preceded declines, though this particular filing provides no information about whether a scheduled trading plan governed the transaction timing.